Study for Comparison between Tramadol and dexmedetomidine for treatment of post-spinal anaesthesia shivering
Not Applicable
- Conditions
- Health Condition 1: 7- Osteopathic
- Registration Number
- CTRI/2021/03/032090
- Lead Sponsor
- Dr DYPatil Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
>Patient giving consent
>patients of either gender aged 18-65 years scheduled for elective lower abdominal, lower limb surgeries under spinal anaesthesia
>American Society of Anesthesiologist physical status class I and II
Exclusion Criteria
•Patients with known hypersensitivity to dexmedetomidine or tramadol, cardio-pulmonary, renal or hepatic disease, hyperthyroidism, psychiatric disorder, urinary tract infection, severe diabetes or autonomic neuropathies, known history of substance or alcohol abuse, patients receiving any pre-medication.
•cesarean section
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cessation of shivering , Episodes of recurrenceTimepoint: shivering ceasing within 15 min after treatment , time of recurrence after treatment
- Secondary Outcome Measures
Name Time Method Adverse effects such as nausea, vomiting, bradycardia (50/min), hypotension (20% of baseline), dizziness; and sedation score will be noted. The degree of sedation will be graded on a four-point scale as Grade 1: Awake and alert, Grade 2: Drowsy, responsive to verbal stimuli, Grade 3: Drowsy, arousable to physical stimuli, Grade 4: UnarousableTimepoint: every 15 min interval hemodynemic changes